Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x100px

Person › Details

John Baldoni (GlaxoSmithKline plc (LSE: GSK, NYSE: GSK))

Baldoni, John (GSK 201205 SVP Platform + Technology Science)

	Organisation	GlaxoSmithKline plc (LSE: GSK, NYSE: GSK)
	Today	GSK plc (LSE: GSK, NYSE: GSK)
	Group	GSK (Group)
	Product	drug discovery technology
	Product 2	drug development technology

Record changed: 2018-02-20

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for John Baldoni

[1] GlaxoSmithKline plc. (10/27/17). "Press Release: Public-private Consortium Aims to Cut Preclinical Cancer Drug Discovery from Six Years to Just One". San Francisco, CA....
[2] Exscientia Ltd.. (7/2/17). "Press Release: Exscientia Enters Strategic Drug Discovery Collaboration with GSK. Pre-clinical Collaboration Focused on up to 10 Targets Nominated by GSK"....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]